Victoza Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Conditions:   Type 2 Diabetes Mellitus;   Cardiovascular Diseases Interventions:   Drug: SU;   Drug: DPP4;   Drug: SGLT2i;   Drug: GLP-1RA;   Drug: SGLT2i or GLP-1RA;   Drug: Linagliptin (DPP4);   Drug: Exenatide (GLP-1RA);   Drug: Liraglutide (GLP-1RA);   Drug: Empagliflozin (SGLT2i);   Drug: Glimepiride (SU);   Drug: Glipizide (SU);   Drug: Gli mepiride (SU) or Glipizide (SU);   Drug: SU or DPP4 (excluding saxagliptin and alogliptin);   Drug: Exenatide (GLP-1RA) or Liraglutide (GLP-1RA) Sponsors:   Kaiser Permanente;   Geisinger Clinic;   Henry Ford Health System;   He...
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials